In conclusion, our computational analyses allowed the identification of a putative novel GBM-type expressing high levels of mGlu3 and mGlu5 receptors, as well as other genes related to glutamatergic and GABAergic neurotransmission. This evidence concerns the gene GRM3 and glioblastoma.